Origin
YC W26San Francisco, US · Founded 2025 · 4 employees · 2 known investors
Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.
Founders & leadership· Y Combinator alumni (W26)
Origin was founded in 2025 by Yash Rathod, Malhar Bhide, and Founder of Siren Biotechnology.
YR
Yash Rathodin𝕏Co-founder · CEOYash Rathod studied computer science at UIUC and has conducted research in computer vision and reinforcement learning. He is the CEO of Origin.
MB
Malhar Bhidein𝕏Co-founder · CTOMalhar Bhide studied computer science at UIUC and has worked in ML research roles at Wadhwani AI and Automorphic (YC S23), where he now serves as CTO at Origin.
FO
Founder of Siren BiotechnologyFounder & CEO, Siren Biotechnology · UCSF
UM
Unnamed MIT ProfessorProfessor of Computer Science, MIT · Broad Institute
DA
Dean at Grainger College of Engineering, UIUCDean, Grainger College of Engineering, UIUC
Investors · 2
Funding
SEC filings, press & company announcements$10B disclosed across 1 round · 2026
- $10BraisedJul 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 3
by search overlap
bio17 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Form Bio15 shared keywordsForm Bio develops AI-driven software and bioinformatics tools for genetic medicine and genome engineering, enabling faster and safer design of gene therapies, protein engineering, and manufacturing optimization.
Formation Bio12 shared keywordsFormation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.
Companies competing with Origin for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Jeff Bezos Put $2 Billion of His Own Money Into Blue Origin's Funding Round | The Motley Foolfool.com · Jul 2026
Kent-based Blue Origin seeks $10 billion in outside funding | Kent Reporterkentreporter.com · Jul 2026
Blue Origin seeks to raise $10 billion in outside capital - SpaceNewsspacenews.com · Jul 2026
Techbuzztechbuzz.ai · Jul 2026
Blue Origin raises $10B in first external funding round at $130B valuationproactiveinvestors.com · Jul 2026Frequently asked questions
- What does Origin do?
- Origin generates spatial molecular maps from patient tumor samples to enable cancer biology research in native tissue context. The platform combines spatial transcriptomics, imaging, and functional perturbation assays on fresh and archived tumors, paired with AI models for drug response prediction and target discovery.
- Who founded Origin?
- Origin was founded by Yash Rathod, Malhar Bhide, Founder of Siren Biotechnology in 2025.
- Who are Origin's investors?
- Origin's investors include Glasswing Ventures, Y Combinator.
- How much funding has Origin raised?
- Origin has disclosed $10B raised across 1 round.
- Where is Origin headquartered?
- Origin is headquartered in San Francisco, US.